Spanish Registry of Systemic Treatments in Psoriasis
Status: Recruiting
Location: See all (13) locations...
Study Type: Observational
SUMMARY
The purpose of Biobadaderm is a to study the safety of systemic therapy in psoriasis.
Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: f
View:
• For biologics group: all consecutive psoriasis patients who begin any biological therapy
• For classic systemic group: the next psoriasis patients who begin, for the first time, a nonbiologic systemic treatment (after including a patient in the biologics group)
Locations
Other Locations
Spain
Fundación Hospital Alcorcón
RECRUITING
Alcorcón
Hospital General Universitario de Alicante
RECRUITING
Alicante
Hospital Universitari German Trias y Pujol.
RECRUITING
Badalona
Hospital Clinic
RECRUITING
Barcelona
Hospital del Mar. IMAS
RECRUITING
Barcelona
Hospital Universitario Reina Sofía
RECRUITING
Córdoba
Hospital Universitario de Gran Canaria Dr Negrín
RECRUITING
Las Palmas
Hospital Infanta Leonor
RECRUITING
Madrid
Hospital Universitario 12 de Octubre
RECRUITING
Madrid
Hospital Universitario de la Princesa
RECRUITING
Madrid
Hospital Clínico Universitario Virgen de la Victoria
RECRUITING
Málaga
Hospital Universitario Virgen Macarena de Sevilla
RECRUITING
Seville
Hospital General Universitario de Valencia
RECRUITING
Valencia
Contact Information
Primary
Ignacio Garcia-Doval, PhD, MScEpid
investigacion@aedv.es
34- 915446284
Time Frame
Start Date: 2008-10
Estimated Completion Date: 2025-10
Participants
Target number of participants: 3500
Treatments
New drugs
Cohort exposed to biologic therapy, apremilast or fumarates
Classic systemic therapy
Non-biological systemic treatment (methotrexate, cyclosporine and acitretin) Phototherapy was accepted as systemic therapy only in the small group of patients retrospectively included(PUVA, UVB 311).
Related Therapeutic Areas
Sponsors
Collaborators: Boehringer Ingelheim, Merck Sharp & Dohme LLC, Eli Lilly and Company, AbbVie, LEO Pharma, Janssen, LP, Novartis, Bristol-Myers Squibb, Amgen, Spanish Agency of Medicines and Health Products, Pfizer, UCB Pharma, Almirall, SAS
Leads: Fundación Academia Española de Dermatología